Skip to main content
Livermore
Livermore
ZHEN

Macquarie Group Ltd

SEC CIK
0001418333
Latest filing
Aug 14, 2026

TBPH holding history

Theravance Biopharma, Inc. in every 13F filed by Macquarie Group Ltd, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

TBPH overviewAll 13F holders of TBPHFull Q2 2026 holdings

Shares (Q4 2025)
0
Sold out in Q4 2025
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of TBPH by Macquarie Group Ltd, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20250$00.0%−208,783−100.0%Sold outHolders
Q3 2025208,783$3.05M<0.1%00.0%UnchangedHolders
Q2 2025208,783$2.30M<0.1%00.0%UnchangedHolders
Q1 2025208,783$1.86M<0.1%00.0%UnchangedHolders
Q4 2024208,783$1.97M<0.1%00.0%UnchangedHolders
Q3 2024208,783$1.68M<0.1%−709−0.3%ReducedHolders
Q2 2024209,492$1.78M<0.1%+709+0.3%AddedHolders
Q1 2024208,783$1.87M<0.1%00.0%UnchangedHolders
Q4 2023208,783$2.35M<0.1%00.0%UnchangedHolders
Q3 2023208,783$1.80M<0.1%00.0%UnchangedHolders
Q2 2023208,783$2.16M<0.1%00.0%UnchangedHolders
Q1 2023208,783$2.27M<0.1%00.0%UnchangedHolders
Q4 2022208,783$2.34M<0.1%−5,296−2.5%ReducedHolders
Q3 2022214,079$2.18M<0.1%−633−0.3%ReducedHolders
Q2 2022214,712$1.95M<0.1%00.0%UnchangedHolders
Q1 2022214,712$2.05M<0.1%00.0%UnchangedHolders
Q4 2021214,712$2.37M<0.1%00.0%UnchangedHolders
Q3 2021214,712$1.59M<0.1%−75,546−26.0%ReducedHolders
Q2 2021290,258$4.21M<0.1%+208,783+256.3%AddedHolders
Q1 202181,475$1.66M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.